ANCA相关性血管炎伴严重肾病患者肾脏恢复与进展至终末期肾病的预测因素
该回顾性队列研究纳入166例活检证实的活动性AAV-GN且诊断时eGFR<15 ml/min/1.73 m2的患者,分析肾脏恢复、脱离透析及持续ESKD的预测因素。结果显示肾脏恢复取决于诊断时血沉、血清肌酐及轻微或轻度慢性化改变;脱离透析的预测因素为活检轻微慢性化改变;持续ESKD的预测因素包括诊断时较高血清肌酐及中重度慢性化改变;加用血浆置换未影响上述结局。
要点
- 诊断时血清肌酐和肾活检慢性化程度是预测肾脏恢复的关键因素。
- 活检显示轻微慢性化改变者脱离透析的几率更高。
- 加用血浆置换未改善肾脏恢复或降低持续ESKD风险。
核心结论
- 在AAV-GN且eGFR<15 ml/min/1.73 m2的患者中,肾脏恢复、脱离透析及持续ESKD取决于诊断时血清肌酐和肾活检组织学表现,加用血浆置换未影响这些结局。
研究设计与样本
- 回顾性队列研究,纳入166例MPO-ANCA或PR3-ANCA阳性且诊断时eGFR<15 ml/min/1.73 m2的AAV-GN患者,其中84例接受糖皮质激素+环磷酰胺诱导,72例接受糖皮质激素+利妥昔单抗诱导,49例接受血浆置换。
主要发现
- 肾脏恢复的预测因素为红细胞沉降率、诊断时血清肌酐及轻微或轻度慢性化改变。
- 在71例诊断后4周内开始透析的患者中,脱离透析的预测因素为诊断时肾活检轻微慢性化改变(OR=6.138;95%CI:1.389-27.118;P=0.017)。
- 持续ESKD的预测因素包括诊断时较高血清肌酐(IRR=1.086;95%CI:1.005-1.173;P=0.037)、中度慢性化改变(IRR=3.797;95%CI:1.090-13.225;P=0.036)和重度慢性化改变(IRR=5.883;95%CI:1.542-22.439;P=0.009)。
临床怎么用
- 对AAV-GN伴严重肾功能损害患者,诊断时血清肌酐和肾活检慢性化程度可用于预判肾脏恢复及脱离透析的可能性。
- 血浆置换未显示改善肾脏结局,临床决策应综合评估其获益与风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: A significant number of patients with antineutrophil cytoplasmic antibodies (ANCA)- associated vasculitis (AAV) with glomerulonephritis (AAV-GN) still progress to end-stage kidney disease (ESKD, estimated glomerular filtration rate [eGFR] <15 ml/min per 1.73 m2) despite advances in remission-induction treatment. METHODS: This is a retrospective cohort study on myeloperoxidase (MPO)-ANCA or proteinase 3 (PR3)-ANCA positive patients with AAV (microscopic polyangiitis, MPA; or granulomatosis with polyangiitis, GPA) and eGFR <15 ml/min per 1.73 m2 or ESKD at presentation. Renal recovery, dialysis discontinuation, and persistence of ESKD after standard remission-induction, with or without the use of plasma exchange (PLEX) were analyzed. RESULTS: We analyzed 166 patients with biopsy-proven active AAV-GN and eGFR <15 ml/min per 1.73 m2 at the time of diagnosis. Patients received glucocorticoids with cyclophosphamide (CYC) (n = 84) or with rituximab (RTX) (n = 72) for remission-induction, and 49 received PLEX. The predictors of renal recovery were erythrocyte sedimentation rate, serum creatinine (SCr) at diagnosis, and minimal or mild chronicity changes. We further analyzed 71 patients who started dialysis with or without PLEX within 4 weeks of AAV-GN diagnosis. The predictors of dialysis discontinuation were minimal chronicity changes in kidney biopsy at diagnosis (odds ratio = 6.138; 95% confidence interval [CI]: 1.389-27.118; P = 0.017). Predictors of persistence of ESKD within 12 months included higher SCr at diagnosis (incidence rate ratio [IRR] = 1.086; 95% CI: 1.005-1.173; P = 0.037), and moderate (IRR = 3.797; 95% CI: 1.090-13.225; P = 0.036), or severe chronicity changes in kidney biopsy (IRR = 5.883; 95% CI: 1.542-22.439; P =0.009). CONCLUSION: In our cohort, kidney recovery, dialysis discontinuation, and persistence of ESKD in patients with AAV-GN and eGFR <15 ml/min per 1.73 m2 depended on SCr and histologic findings on kidney biopsies at the time of diagnosis and was not affected by the addition of PLEX.
引用
- Casal Moura M, Zubidat D, Liebana MP, et al. Predictive Factors of Renal Recovery and Progression to End-Stage Kidney Disease in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis With Severe Kidney Disease. Kidney Int Rep. 2024. PMID: 38707835. doi:10.1016/j.ekir.2024.02.1431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。